35 results about "Mogroside" patented technology

The invention discloses siraitia grosvenorii and stevia rebaudiana flavored syrup and a preparation method thereof, and belongs to the field of food processing. The syrup is prepared from 72%-99% of water, 0%-26% of erythritol, 0%-1% of mogroside, 0%-0.2% of stevioside and citric acid lt. 0.3% of potassium sorbate; the mass ratio of the mogroside to the stevioside is (1-5): 1, and the pH value of the mogroside and the stevioside is 3.5-5.5. The preparation method comprises the steps of raw material preparation, mixing and stirring, pH value adjustment, sterilization treatment, preservative addition and packaging. Through synergistic compounding of the sweetening agent and process optimization, the problems that an existing product is not coordinated in flavor and poor in stability are solved, and the product is fresh, sweet, free of peculiar smell, long in storage life, suitable for the fields of beverages, baking and the like and good in application value.

A fragrance composition is provided. The composition comprises mogroside selected from the group consisting of symbioside I, 1,6-α isomers of symbioside I, and combinations thereof, and aromatic components selected from the group consisting of 4-hydroxy-2H-furan-5-one, ethylfuranone, maltol, vanillin, benzaldehyde, and combinations thereof.

The invention discloses a group of glycosyl transferase genes and application of the glycosyl transferase genes in preparation of mogroside, the glycosyl transferase genes are two new glycosyl transferase genes obtained by mining in a siraitia grosvenorii genome for the first time, are respectively named as UGT153033 and UGT30033, and have nucleotide sequences as shown in SEQ ID NOs: 1 and 2; meanwhile, the invention discloses glycosyl transferase coded by the glycosyl transferase gene and a mutant of the glycosyl transferase, wherein the glycosyl transferase and the mutant are respectively shown as SEQ ID NOs: 3-11; meanwhile, the invention also discloses a nucleic acid construct or an expression vector containing the gene or expressing the glycosyl transferase, and a host cell transformed by the nucleic acid construct or the expression vector. A new gene is provided for artificially synthesizing mogroside monomers, and the defects that the number of genes related to existing mogroside biosynthesis is small, and the molecular synthesis mechanism of most mogroside compounds is not clear yet are overcome.

The present invention belongs to the medical and technical field and provides a medicine or health food composition of nicotinamide mononucleotide and mogroside. In addition, the present invention also provides the preparation method, formulation and application of the composition.

This invention discloses a medicinal and edible herbal health-preserving formula, its preparation process, and a beverage, belonging to the field of medicinal and edible health-preserving food technology. It aims to solve the problems of conventional formula ratios, outdated processes, loss of active ingredients, poor beverage quality, and easy duplication with existing technologies. The formula consists of drinking water, dried plum, hawthorn, poria cocos, and other medicinal and edible components, as well as erythritol and mogrosides, without any additional additives. The proportions of each component are unique, avoiding conventional ratios in existing technologies. The preparation process includes raw material pretreatment, graded extraction, secondary extraction, merging and concentration, flavoring and homogenization, sterilization, and bottling. Each process parameter has been optimized, employing low-temperature processing and graded extraction technology to maximize the preservation of the active ingredients of the herbal raw materials. The resulting beverage is a light amber-colored clear liquid with a moderately sweet and sour taste, a herbal aroma, high active ingredient content, no sucrose or preservatives, a long shelf life, and is suitable for daily health-preserving consumption by various groups.

The present application relates to the technical field of health food, in particular to a plant composite powder and a preparation method and application thereof. The plant composite powder comprises the following components in parts by weight: 1-20 parts of small green oranges, 1-30 parts of Chinese yam, 3-30 parts of perilla leaves, 10-50 parts of lilies, 1-10 parts of fried small red beans, 0.1-1 parts of white kidney beans, 1-30 parts of snow pears, 0.1-5 parts of white horse beans, and 0.05-1 parts of mogroside. The present application combines lilies and small green oranges with the effect of soothing nerves and helping sleep with perilla leaves with the effect of promoting lung and dredging collaterals, and adds Chinese yam and white horse beans for invigorating spleen and replenishing qi, fried small red beans and white kidney beans for removing dampness and swelling, snow pears for nourishing yin and moistening dryness, and mogroside for adjusting flavors, to form a synergistic formula based on the theory of heart-spleen-lung coordination, so as to achieve the dual effects of improving sleep and relieving allergic rhinitis.

Compositions and consumables comprising at least one D-sugar or L-sugar and a non-sucrose sweetener (e.g., a steviol glycoside sweetener or mogroside sweetener) are provided herein. Methods for modulating one or more taste attributes, included enhancing sweetness, improving temporal profile, reducing sweet linger, reducing bitterness, improving mouthfeel, improving taste and / or sweet intensity, of a consumable are disclosed. The compositions and methods can be used to make a consumable taste more like a sucrose-sweetened consumable.

The invention provides a preparation method of dried orange peel and dark plum effervescent tablets and application of the dried orange peel and dark plum effervescent tablets in promoting digestion and relieving cough, and belongs to the technical field of pharmaceutical preparations. The preparation method of the dried orange peel and dark plum effervescent tablet comprises the following steps: extracting dried orange peel and dark plum to obtain an extracting solution; concentrating and drying the extracting solution to obtain dried orange peel and dark plum extract powder; equally dividing the dried orange peel and dark plum extract powder into two parts, respectively adding citric acid and sodium bicarbonate, spraying a 9.5% povidone-ethanol solution, and drying to obtain acid granules and alkali granules; and mixing the acid granules, the alkali granules, lactose, PEG 6000 and mogroside, tabletting and drying to obtain the dried orange peel and dark plum effervescent tablets. The dried orange peel and dark plum effervescent tablet prepared by the invention is short in disintegration time limit and good in taste, can effectively avoid the sticking problem, has the effects of relieving or treating functional dyspepsia and cough, and can be used for preparing related health care products and medicines.

The invention provides a ginseng tissue culture adventitious root wall-broken pure powder tablet rich in rare ginsenoside and a preparation method of the ginseng tissue culture adventitious root wall-broken pure powder tablet rich in rare ginsenoside. The method comprises the steps that fresh ginseng tissue culture adventitious roots are subjected to heat-moisture treatment for 60-100 min at the temperature of 110-121 DEG C and then treated through freeze-drying processes of pre-freezing, sublimation drying and desorption drying till the water content is smaller than 5%, and the ginseng tissue culture adventitious root wall-broken pure powder tablet rich in rare ginsenoside is obtained. Then wall-breaking and crushing at the low temperature of-20 to-30 DEG C until the particle size D90 is less than 20 microns, adding 0.1-1 per thousand of mogroside or stevioside, mixing, granulating by a dry method, and tabletting to obtain a finished product. The content of rare ginsenoside is remarkably increased through heat-moisture treatment, and the synergistic effect of freeze drying, low-temperature wall breaking and dry granulation is combined, so that the tablet is fine and smooth in taking, free of slag and granular feeling, free of radiation residues, only added with a trace amount of a natural sweetening agent, outstanding in pure natural property, suitable for large-scale production, high in efficacy and excellent in taste, and suitable for large-scale production. The marketization requirements of functional foods are met.

A flavor composition is provided. The composition includes at least one triterpenoid compound selected from the group consisting of pterocaryoside B, pterocaryoside A, cyclocarioside K and combinations thereof; and at least one sweetness modifier selected from the group consisting of steviol glycosides, mogrosides, dihydrochalcones, sweet proteins and combinations thereof.

Consumables comprising cyclamate and a steviol glycoside sweetener or mogroside sweetener are provided herein, wherein cyclamate, when present in an amount at or below its sweetness recognition threshold concentration, enhances the sweetness of and, optionally, improves the sweetness profile the sweetener, thereby providing a consumable that tastes more like a sucrose-sweetened consumable. Methods of enhancing the sweetness of a consumable, methods of making a consumable taste more like a sucrose-sweetened consumable and methods of preparing consumables are also detailed herein.

Provided herein are mogrosides containing non-glucose glycosides. Also provided are compositions, including consumables, comprising the mogrosides described herein.

A perfume composition is provided. The present invention relates to a composition comprising rutin and a sweetness modifier selected from the group consisting of mogroside, dihydrochalcone, hesperidin 3-acetate, brazilin, thaumatin, and combinations thereof.

Provided herein are consumer products comprising a non-sucrose sweetener (e.g., a steviol glycoside sweetener or mogroside sweetener) and at least one hydroxybenzoic acid or salt thereof. Consumer products have one or more improved properties, such as improved sweetness characteristics, providing consumer products that taste more sweetened as sucrose consumer products. Also detailed herein are methods of enhancing the sweetness of consumer products, methods of making consumer products sweetened more like sucrose, and methods of making consumer products.

The present invention relates to a nutritional composition, a process for its preparation and its use in improving sleep. The nutritional composition comprises: 90-95% by mass of milk-based powder selected from one or more of the following: whole milk powder, milk protein powder, bovine colostrum powder, whey protein powder, demineralized whey powder and skimmed milk powder; 0.5 to 6.0 mass percent of gamma-aminobutyric acid; 0.5 to 6.0 mass percent of L-theanine; 0.5-4% by mass of sodium carboxymethyl cellulose; 0.05 to 1.0 mass percent of silicon dioxide; 0.01%-1.0% by mass of milk protein peptide; 0.01-1.0% by mass of colostrum peptide powder; 0.05%-1.0% by mass of a compound plant extract; and 0.01-1.0% by mass of a sweetening agent selected from stevioside and / or mogroside.

The invention discloses a PI3K / Akt / HIF-1alpha signal channel inhibitor containing mogroside and application of the PI3K / Akt / HIF-1alpha signal channel inhibitor, and belongs to the field of biological medicine. According to the application, network pharmacology, molecular docking, animal model, cell model and western blot analysis are carried out for the first time, and the mogroside compound is systematically revealed and proved to be capable of efficiently inhibiting activation of a PI3K / Akt / HIF-1alpha signal channel. Based on the original mechanism, the invention provides a brand new application of the compound in preparation of drugs for preventing and / or treating various diseases (such as inflammatory diseases, metabolic diseases, cardiovascular diseases, fibrosis diseases, cerebral arterial thrombosis and malignant tumors) mediated by abnormal activation of the pathway. The invention also provides a corresponding inhibitor and a pharmaceutical composition. The traditional cognition of the mogroside is broken through, and a core scientific basis is provided for developing the mogroside into an innovative medicine with strong targeting property and high safety.

The ion exchange column comprises an upper exchange column body, a lower exchange column body is arranged at the lower end of the upper exchange column body, a first conical surface is arranged on the inner wall of the lower exchange column body and located at the upper end of the lower exchange column body, and a second conical surface is fixedly arranged on the lower end face of the upper exchange column body. The second conical surface is located in the first conical surface and has the same inclination, fixing blocks are arranged on the inner wall of the lower exchange column body, a plurality of fixing blocks are arranged, a filter plate is arranged at the upper end of each fixing block, the filter plates and the fixing blocks are fixedly installed through bolts, and a connecting ring is arranged on the outer wall of the upper exchange column body. The upper exchange column body and the lower exchange column body can be detached by a user by detaching the bolts, so that the inner walls of the upper exchange column body and the lower exchange column body can be cleaned conveniently after the filter plates are used, and the filter plates can be taken down by detaching the bolts on the filter plates, so that the filter plates can be cleaned and replaced conveniently.

Provided are: an oral composition which contains mogrol and has reduced bitterness or astringency; and a composition which contains mogrol and has an effect of suppressing an increase in blood glucose level. [Solution] The present invention prepares: an oral composition comprising (A) 0.001 mass% or more of mogrol and (B) mogrosides containing 1-3 monosaccharides; and a composition for inhibiting an increase in blood glucose level, which contains mogrol as an active ingredient. Also provided is a method for producing an oral composition containing mogrol, said method comprising a step for causing a glycolytic enzyme to act on mogrosides.

The present application relates to the technical field of genetic engineering, and particularly relates to a sucrose phosphorylase mutant and application thereof in synthesis of alpha-mogroside. Streptococcus parasanguinis The present application is obtained by simultaneously mutating amino acid multiple sites of 13th, 206th and 243rd of wild-type sucrose phosphorylase derived from Parahaemolyticus (Parahaemolyticus), and constructing recombinant Escherichia coli by using the sucrose phosphorylase mutant, and then fermenting the recombinant sucrose phosphorylase to significantly improve the efficiency of producing alpha-mogroside by using sucrose and hydroquinone as raw materials. The conversion rate of producing alpha-mogroside by using sucrose and hydroquinone as raw materials can reach 90%, and the product concentration reaches 123 g / L, so the present application has strong industrial application potential.

The invention relates to the technical field of coffee products, and particularly discloses mogroside coffee and a making method thereof. The mogroside coffee is prepared from the following raw materials in parts by weight: 2 to 3 parts of mogroside, 40 to 60 parts of coffee powder, 10 to 30 parts of milk powder, 4 to 9 parts of maltodextrin, 0.3 to 0.5 part of xanthan gum and 0.2 to 0.3 part of silicon dioxide. The preparation method of the mogroside coffee comprises the following steps: mixing the raw materials, adding food-grade ethanol, mixing, passing through a screen to obtain particle materials, drying the particle materials, and finally selecting particles through the screen to obtain the mogroside coffee. According to the application, the aggregation of the high-purity mogroside can be obviously improved, so that the obtained mogroside coffee has better application solubility.

The invention discloses a preparation method of mogroside and a processing device therefor, which relates to the technical field of sweet glycoside preparation. The device includes a collection cabin, a collection pipe, a peeling assembly and a centrifugal separation assembly, wherein the collection cabin is provided with the peeling assembly, the peeling assembly can peel a fresh fructus momordicae, and a peeled pulp enters the collection cabin so that the collection cabin can transport the pulp to the centrifugal separation assembly; the centrifugal separation assembly includes a separation cabin, a disc, a centrifugal cylinder and a filter pipe, wherein the disc is rotatably arranged in the separation cabin, a plurality of the centrifugal cylinders distributed in a circle are fixed at intervals on an outer peripheral side of the disc, the separation cabin being further provided with a liquid injection head corresponding to the centrifugal cylinder.

The application discloses a multi-component effervescent tablet with natural eutectic solvent as components and separation effect on protein. The hydrogen bond donor of the natural eutectic solvent is glycerol, and the hydrogen bond acceptor includes mogroside or stevioside; the carbon dioxide source of the effervescent tablet is sodium carbonate or sodium bicarbonate, and the acid source is citric acid, tartaric acid or fumaric acid. The above natural components are mixed and heated to form the natural eutectic solvent with effervescence, which is then added to the raw powder of the effervescent tablet composed of the carbon dioxide source and the acid source, and the multi-component effervescent tablet loaded with the natural eutectic solvent is obtained by using the pressurization method. The process is simple, fast and low in cost, and is convenient for realizing large-scale production; the prepared effervescent tablet has ideal properties and hardness, small tablet weight difference, and obvious effect in enriching trace protein in the extract of snake slough. The application not only expands the existing use of the eutectic solvent, but also provides a new choice for the separation and enrichment of biological macromolecules.

The invention discloses a composition for improving a skin state and application of the composition. The composition is prepared from the following components in parts by weight: 30 to 45 parts of collagen-centella asiatica nano micro-capsules, 15 to 25 parts of nicotinamide, 20 to 30 parts of compound berry juice powder, 3 to 8 parts of sodium hyaluronate, 0.2 to 0.8 part of mogroside and 0.1 to 0.3 part of compound essence. The collagen-centella nanometer microcapsule is prepared by taking konjac glucomannan, glucan and xylooligosaccharide as compound polysaccharide carriers, taking collagen peptide and centella total shake as core materials, adding vitamin C, calcium chloride and maltodextrin and carrying out a spray drying process. According to the composition prepared by the invention, multiple effects of moisturizing and locking water, improving skin elasticity and compactness, promoting collagen generation and improving periorbital wrinkles are realized through synergism of all the components, the storage is stable, the process is mature and can be industrialized, the safety is high, and a new choice is provided for efficient oral administration for skin care.

The invention relates to the field of coffee beverage processing, in particular to siraitia grosvenorii sugar-free low-caffeine coffee and a making process thereof.The making process comprises the following steps that sodium alginate is added into coffee liquid, stirring and mixing are conducted, then a calcium chloride solution is dropwise added, and reaction liquid is obtained; then standing and filtering to obtain low-caffeine coffee; the low-caffeine coffee is mixed with the siraitia grosvenorii extracting solution and other common components to obtain the siraitia grosvenorii sugar-free low-caffeine coffee. Gel formed by sodium alginate and calcium ions is used for removing caffeine, and substances in the fructus momordicae extracting solution are used for maintaining flavor. Specifically, mogroside inhibits bitter feeling caused by caffeine; the beta-ionone is combined with pyrazine substances in coffee to convert the scorched bitter taste into roasted nut fragrance; linalool is oxidized to catalyze hydrolysis of lactone, so that coffee lactone flower and fruit fragrance can be activated; therefore, the coffee not only can maintain low caffeine, but also can retain flavor, does not need additional sugar, and is healthier to drink.

The invention discloses a natural antiseptic cinnamon chili sauce and a preparation method thereof. The chili sauce is prepared from the following components in parts by weight: 20 to 30 parts of chili, 10 to 20 parts of garlic, 0.5 to 3 parts of ginger, 10 to 20 parts of fermented soya beans, 0.3 to 0.7 part of cinnamon oil (based on pure cinnamon oil), 0.05 to 0.2 part of carbohydrate, 0.1 to 0.4 part of salt, 0.05 to 0.25 part of natural flavor synergist and 20 to 40 parts of edible oil. Wherein the natural flavor synergist is selected from any one or more of mogroside, ammonium glycyrrhizinate, citric acid, malic acid or a hawthorn extract, and the product does not contain chemically synthesized preservatives such as sodium benzoate and potassium sorbate. Through specific component compatibility and process regulation and control, collaborative optimization of natural bacteriostasis and flavor coordination is realized, the normal-temperature shelf life is not less than 6 months, the sensory quality is excellent, and the method is suitable for production of clean label seasonings.

The present disclosure relates to the field of natural sweetener compositions useful in the flavor industry. More particularly, it concerns a composition comprising a natural sweetener selected from the group consisting of steviol glycosides, mogrosides, and any mixture thereof, and a solvent mixture comprising A) propylene glycol or glycerol; B) one or more solvents having Hansen Solubility Parameters δp and δh higher than δp and δh, respectively, of the solvent chosen as solvent A; and C) one or more solvents having Hansen Solubility Parameters δp and δh lower than δp and δh, respectively, of the solvent chosen as solvent A. The present disclosure further relates to the use of the said composition in consumer products, such as flavored products.

The invention provides a foaming type eutectic solvent prepared by using a natural sweetening agent as a raw material and application of the foaming type eutectic solvent as a solubilizer. Stevioside and mogroside are two natural sweeteners with extremely wide application, and not only have high sweetness, but also have a series of biological activities; the natural eutecticevaporate solvent can be formed under the heating condition by combining the two hydrogen bond acceptors with hydrogen bond donors including sorbitol, xylitol, glycerol and 1, 3-butanediol. The product can generate abundant foams and has obvious surfactant performance. In the subsequent application, the squalene is used as a solubilizer for improving the solubility of the hydrophobic component squalene in water, and the application of the squalene in the industries of food, health care, cosmetics and the like is greatly limited due to poor water solubility of the squalene. Results prove that the solubilization rate of the natural eutectic solvent to squalene can reach several times to dozens of times. The green solvent is friendly, safe and easy to prepare, and has good application potential in multiple fields.

The present disclosure provides compositions and methods for producing transgenic plants and other organisms that exhibit increased production of mogroside compounds, in particular mogroside V, and the mogroside compounds, plants and plant parts so produced.

The invention discloses a glycosyl transferase gene and application of the glycosyl transferase gene in preparation of mogroside, the glycosyl transferase gene is named yojK1 and has a nucleotide sequence as shown in SEQ ID NO: 1; the invention also discloses an amino acid sequence coded by the glycosyl transferase gene, wherein the amino acid sequence is as shown in SEQ ID NO: 2. Meanwhile, the invention also discloses a nucleic acid construct or an expression vector containing the gene or expressing the glycosyl transferase, and a host cell transformed by the nucleic acid construct or the expression vector. A new gene is provided for artificially synthesizing mogroside monomers, and the defect that the number of genes related to existing mogroside biosynthesis is small is overcome.